Literature DB >> 23468208

Genetics of arrhythmogenic right ventricular cardiomyopathy.

Oscar Campuzano1, Mireia Alcalde, Catarina Allegue, Anna Iglesias, Pablo García-Pavía, Sara Partemi, Antonio Oliva, Vincenzo L Pascali, Paola Berne, Georgia Sarquella-Brugada, Josep Brugada, Pedro Brugada, Ramon Brugada.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy is a rare clinical entity characterised by fibro-fatty replacement of myocardium, mainly involving right ventricular free wall, leading to malignant electrical instability and sudden cardiac death. The disease is inherited in up to 50% of cases, with incomplete penetrance and variable phenotypic expression. To date, more than 300 pathogenic mutations have been identified in 12 genes, mainly with autosomal dominant inheritance. Here, we focus on recent advances in the genetics of arrhythmogenic right ventricular cardiomyopathy. Despite continuous improvements, current genotype-phenotype studies have not contributed yet to establish a genetic risk stratification of the disease.

Entities:  

Mesh:

Year:  2013        PMID: 23468208     DOI: 10.1136/jmedgenet-2013-101523

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Genetic and toxicologic investigation of Sudden Cardiac Death in a patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) under cocaine and alcohol effects.

Authors:  Francesca Cittadini; Nadia De Giovanni; Mireia Alcalde; Sara Partemi; Arnaldo Carbone; Oscar Campuzano; Ramon Brugada; Antonio Oliva
Journal:  Int J Legal Med       Date:  2014-11-16       Impact factor: 2.686

Review 2.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

Review 3.  Medico-legal perspectives on sudden cardiac death in young athletes.

Authors:  Antonio Oliva; Vincenzo M Grassi; Oscar Campuzano; Maria Brion; Vincenzo Arena; Sara Partemi; Monica Coll; Vincenzo L Pascali; Josep Brugada; Angel Carracedo; Ramon Brugada
Journal:  Int J Legal Med       Date:  2016-09-21       Impact factor: 2.686

Review 4.  Unmasking the molecular link between arrhythmogenic cardiomyopathy and Brugada syndrome.

Authors:  Javier Moncayo-Arlandi; Ramon Brugada
Journal:  Nat Rev Cardiol       Date:  2017-07-13       Impact factor: 32.419

Review 5.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.

Authors:  Babken Asatryan; Argelia Medeiros-Domingo
Journal:  J Mol Med (Berl)       Date:  2018-08-20       Impact factor: 4.599

Review 6.  Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges.

Authors:  Bruno Pinamonti; Francesca Brun; Luisa Mestroni; Gianfranco Sinagra
Journal:  World J Cardiol       Date:  2014-12-26

7.  Clinical Classification of Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Yulia Lutokhina; Olga Blagova; Alexander Nedostup; Svetlana Alexandrova; Anna Shestak; Elena Zaklyazminskaya
Journal:  Pulse (Basel)       Date:  2020-02-11

8.  An autopsy case of infantile-onset vanishing white matter disease related to an EIF2B2 mutation (V85E) in a hemizygous region.

Authors:  Yukiko Hata; Koshi Kinoshita; Kazushi Miya; Keiichi Hirono; Fukiko Ichida; Koji Yoshida; Naoki Nishida
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications.

Authors:  M Alcalde; O Campuzano; C Allegue; M Torres; E Arbelo; S Partemi; A Iglesias; J Brugada; A Oliva; A Carracedo; R Brugada
Journal:  Int J Legal Med       Date:  2014-05-16       Impact factor: 2.686

10.  Hippo activation in arrhythmogenic cardiomyopathy.

Authors:  Yong Hu; William T Pu
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.